Lv0
0 积分 2025-09-02 加入
The efficacy and safety of Nivolumab combined with Ipilimumab in the immunotherapy of cancer: a meta-analysis
3小时前
已完结
Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers
17天前
已完结
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
1个月前
已完结
Interpretable machine learning analysis of immunoinflammatory biomarkers for predicting CHD among NAFLD patients
2个月前
已完结
The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy
3个月前
已完结
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
3个月前
已完结
Peripheral blood neutrophils contribute to Claudin18.2-specific CAR-T cell treatment resistance in advanced gastric cancer
4个月前
已完结
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial
4个月前
已完结
皖公网安备34019202002308
